Table 3. Perioperative outcomes.
| Variables | Total number (N=49) |
|---|---|
| Operative time (min) | |
| Range | 60–180 |
| Median | 120 |
| Blood loss (mL) | |
| Range | 10–100 |
| Median | 20 |
| Chest tube duration (days) | |
| Range | 1–5 |
| Median | 2 |
| Postoperative hospital stay (days) | |
| Range | 2–15 |
| Median | 4 |
| Postoperative complications | |
| Pneumonia | 3 |
| Tumor size (cm) | |
| Range | 0.7–1.9 |
| Median | 1.0 |
| Types of LN dissection | |
| Lobe-specific LN dissection | 30 |
| Systemic LN sampling | 19 |
| Number of LNs dissected | |
| Range | 2–12 |
| Median | 6 |
| Histologic subtypes of the basal segmental lesions | |
| AIS | 3 |
| MIA | 31 |
| Invasive AC (LPA) | 15 |
| Synchronous multiple primary lung cancer | |
| Yes | 19 |
| No | 30 |
| Pathological TNM stages for the basal segmental lesions | |
| 0 | 3 |
| IA1 | 33 |
| IA2 | 13 |
LN, lymph node; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; AC, adenocarcinoma; LPA, lepidic-predominant adenocarcinoma; TNM, tumor, node, metastasis.